SHC News & Events

Net revenues in the range of $1.233 billion to $1.251 billion, representing constant currency growth of 5.0% to 6.5% and an estimated 100bps foreign currency benefit, consensus $1.23B; Adjusted EBITDA in the range of $632 million to $641 million, representing constant currency growth of 5.5% to 7.0% and an estimated 100bps foreign currency benefit; Interest expense in the range of $135 million to $145 million; Tax rate applicable to Adjusted Net Income in the range of 27.0% to 29.0%; Adjusted EPS in the range of $0.93 to $1.01; A weighted-average fully diluted share count in the range of 289 million to 291 million shares; Capital expenditures in the range of $175 million to $225 million.

Effective April 1, 2026, Alex Dimitrief, Senior Vice President and General Counsel, will transition to an outside advisor to the Company. Erika Ostrowski, who has served as Sotera Health's Vice President, Deputy General Counsel and Corporate Secretary for the last two years under Alex's leadership, will be promoted to Senior Vice President and General Counsel, effective April 1, 2026.